Effects of neuromuscular blockers on carnosine levels in rat skeletal muscle.
A 30-min treatment with neuromuscular blocking doses of either physostigmine or d-tubocurarine was associated with a 44% or 36% (respectively) reduction in rat skeletal muscle carnosine levels in vivo.
D000818:Animals; D000861:Anserine / Q000378:metabolism; D002336:Carnosine / Q000378:metabolism*; D004151:Dipeptides / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014403:Tubocurarine / Q000494:pharmacology*
D004151:Dipeptides; D002336:Carnosine; D010830:Physostigmine; D000861:Anserine; D014403:Tubocurarine